Showing results (131-140 of 138) with videos related to
Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Frontiers in Immunology|March 7, 2022
Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in GermanyAlex Dulovic, Barbora Kessel, Manuela Harries, et al.Vaccine|December 19, 2023
9-Month observational Dia-Vacc study of vaccine type influence on SARS-CoV-2 immunity in dialysis and kidney transplant patientsJulian Stumpf, Leona Anders, Torsten Siepmann, et al.The Lancet Regional Health. Europe|April 18, 2022
Risk of strong antibody decline in dialysis and transplant patients after SARS-CoV-2mRNA vaccination: Six months data from the observational Dia-Vacc studyJulian Stumpf, Jörg Schwöbel, Tom Lindner, et al.Neuro-Oncology|May 6, 2023
Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastomaMichael C Burger, Marie-Therese Forster, Annette Romanski, et al.The Journal of Clinical Investigation|November 3, 2022
One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patientsSixten Körper, Beate Grüner, Daniel Zickler, et al.Nature Communications|June 8, 2021
SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive careClemens Gutmann, Kaloyan Takov, Sean A Burnap, et al.The Lancet Regional Health. Europe|July 28, 2021
Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccineJulian Stumpf, Torsten Siepmann, Tom Lindner, et al.Journal of Extracellular Vesicles|January 5, 2016
Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paperThomas Lener, Mario Gimona, Ludwig Aigner, et al.Pageof 14